Eagle Pharma Outsourcing LLC recalls PHENYLephrine HCL Infusion
- Recalling company
- Eagle Pharma Outsourcing LLC
- Product
- PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Oct 8, 2026
- Reported
- Nov 4, 2026
- Distribution
- Nationwide within the U.S
- Status
- Ongoing
- Quantity
- 50 250 mL-containers
- Lot / codes
- Lot: PHENYL100-1004, Expiry: 12/31/2026.
- Company location
- Hoover, AL
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0105-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0105-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.